Genomelink is a DNA App Store. If you’ve taken a DNA test from Ancestry or 23andMe, you can upload your data to Genomelink to unlock a wide range of DNA apps: a 2,000+ region ancestry breakdown, insights from 400+ ancient DNA samples, analysis of 350+ genetic traits, unique DNA matches, and more.
Genomelink is a Y Combinator company in the Summer 2021 batch. Its directory entry describes it as: DNA App Store. The founders listed are Tomohiro Takano (Founder), Kensuke Numakura (Founder) (Y Combinator directory entry, June 23, 2021).
Get an email when Genomelink changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
Genomelink is a DNA App Store. If you’ve taken a DNA test from Ancestry or 23andMe, you can upload your data to Genomelink to unlock a wide range of DNA apps: a 2,000+ region ancestry breakdown, insights from 400+ ancient DNA samples, analysis of 350+ genetic traits, unique DNA matches, and more.
Explore our latest genealogy app, YourRoots (https://yourroots.com/), which transforms your family tree into an interactive global map visualization.
We believe consumer genomics today is where the internet was in the 1990s. Over 50 million people in the U.S. have already tested their DNA, and this number will grow into the billions globally in the coming decades. Genomelink aims to become the default DNA data hub and app store for this genomic future.
Our mission:
- Build the world’s #1 platform for consumer genomics apps
- Help people discover their family roots and unite the world
- Create an infruscrucure for consumer genomics
Tomohiro Takano
Founder
Kensuke Numakura
Founder
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 120 companies held here in Healthcare › Consumer Health and Wellness.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Genomelink?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Genomelink: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Genomelink covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Genomelink: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
